PTAFR and ovarian cancer: It has also been reported that ovarian cancer cell lines treated with PAF increase spheroid formation, promote ovarian cancer progression, induce chemoresistance, and significantly upregulate progenitor gene expression via PAF/PAFR-mediated inflammatory signaling pathways [36].